ExchangeCME :: Supporter Group

These activities have been supported by independent educational grants from AstraZeneca

Autoimmune

Unlocking Novel Paths to Patient Care

Richard A. Furie, MD; Elena M. Massarotti, MD;
Eric Morand, MBBS (Hons), PhD, FRACP

A Foundation for Managed Care

Bruce S. Spinowitz, MD; Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF

Cardiovascular and Renal Outcomes
With SGLT2 Inhibitors

Daniel Einhorn, MD, FACE, FACP; Serge A. Jabbour, MD, FACP, FACE; Marc S. Sabatine, MD, MPH; Kumar Sharma, MD

New Pathways to Patient Management

Jonathan Corren, MD; Monica Kraft, MD; Reynold A. Panettieri, Jr, MD

Best Practices for Primary Care

Fernando J. Martinez, MD, MS

A Focus on Exacerbation Prevention

Charles P. Vega, MD, FAAFP

The Clinical and Utilization Benefits of Exacerbation Prevention

Barry J. Make, MD; Richard H. Stanford, PharmD, MS; Barbara P. Yawn, MD, MSc, FAAFP